MUC1 and cancer: Regarding the immunomodulatory capacity of these proteins, MUC1 and MUC16 were found to mask TLR signaling, resulting in the reduction of effector T cell functions, therefore enhancing cancer cell immune evasion and metastasis (Bhatia et al., 2019).